Following a ruling from a U.S. appellate court docket, the authorized battle over the FDA’s expanded entry to abortion tablet mifepristone is heading to the Supreme Court docket. Yahoo Finance Authorized Reporter Alexis Keenan particulars the timeline of mifepristone’s FDA approval and the judicial assessment following restrictive measures on abortion entry within the U.S.
Subscribe to Yahoo Finance:
About Yahoo Finance:
At Yahoo Finance, you get free inventory quotes, up-to-date information, portfolio administration sources, worldwide market information, social interplay and mortgage charges that enable you to handle your monetary life.
Yahoo Finance Plus: With a subscription to Yahoo Finance Plus get the instruments you might want to make investments with confidence. Uncover new alternatives with knowledgeable analysis and funding concepts backed by technical and elementary evaluation. Optimize your trades with superior portfolio insights, elementary evaluation, enhanced charting, and extra.
To be taught extra about Yahoo Finance Plus please go to:
Join with Yahoo Finance:
Get the most recent information:
Discover Yahoo Finance on Fb:
Comply with Yahoo Finance on Twitter:
Comply with Yahoo Finance on Instagram:
Comply with Yahoo Finance Premium on Twitter: